Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Treatment of hepatitis C can be successful in a prison population

Editor's pick
News-Medical.net
9 October 2012
Hepatitis C treatment

Don't rule out IFN/ribavirin for HIV patients with hep C cirrhosis: study

Editor's pick
HCV New Drugs Research
3 October 2012
Hepatitis C treatment

Higher levels of adherence to hepatitis C therapy improve treatment outcomes in people with hepatitis C and HIV

News
3 October 2012
Hepatitis C treatment

Ordeal of hepatitis C treatment worth it

Editor's pick
San Francisco Chronicle
12 September 2012
Hepatitis C treatment

Challenges remain in reaching 100% cure rate in HCV

Editor's pick
Healio Infectious Disease News
11 September 2012
Hepatitis C treatment

Pre-emptive Escitalopram Can Prevent Depression during Hepatitis C Treatment

Editor's pick
HIVandHepatitis.com
24 August 2012
New & experimental hepatitis C treatment

Australia: New drugs offer hope to hepatitis C sufferers

Editor's pick
Sydney Morning Herald
24 August 2012
Hepatitis C treatment

Copy of Interferon, High Blood Pressure May be Risk to Vision

Editor's pick
Kaiser Daily Global Health Policy Report
23 August 2012
Hepatitis C treatment

Interferon, High Blood Pressure May be Risk to Vision

Editor's pick
AIDSMeds
23 August 2012
Hepatitis C treatment

Vitamin B12 During Hepatitis C Treatment

Editor's pick
Hepatitis Central
22 August 2012
Hepatitis C treatment

No benefit to ribavirin maintenance therapy in HCV patients after liver transplant

Editor's pick
HCV New Drugs Research
22 August 2012
Hepatitis C treatment

London Mayor welcomes news of prestigious 2014 medical conference

Editor's pick
European Association for the Study of the Liver (EASL)
14 August 2012
Hepatitis C treatment

No evidence of an interaction between abacavir and ribavirin

News
17 July 2012
Access to healthcare

Activists in the EECA demand a tenfold reduction of the price for pegylated interferons

Editor's pick
EATG
2 July 2012
Hepatitis C treatment

Hepatitis C treatment under threat from welfare reform

Editor's pick
Herald Scotland
24 June 2012
Hepatitis C treatment

Pakistan: Hepatitis C treatment crisis in Punjab

Editor's pick
Pakistan Daily Times
9 June 2012
Hepatitis C treatment

Hep C Top Social Networks and Blogs

Editor's pick
HCV New Drugs Research
4 June 2012
Hepatitis C treatment

FDA says Vertex promotional material overstates benefits of hepatitis C drug

Editor's pick
Boston Globe
31 May 2012
New & experimental hepatitis C treatment

GSK seeks to expand low-platelet drug Promacta to hepatitis C patients

Editor's pick
MedCity News
31 May 2012
Hepatitis C treatment

HCV patients may be able to delay therapy

Editor's pick
MedPage Today
23 May 2012
Hepatitis C treatment

Standard hepatitis C therapy improves insulin resistance in HIV/hepatitis C co-infected patients

News
16 May 2012
New & experimental hepatitis C treatment

BI 201335 & BI 207127 and ribavirin shows good efficacy, including hepatitis C patients with cirrhosis

News
15 May 2012
Hepatitis C treatment

Ribavirin dose reduction is effective for managing anaemia in patients using boceprevir or telaprevir

News
11 May 2012
Hepatitis C treatment

Depression and pegylated interferon: doctors look at screening strategies and treatment

News
9 May 2012